Skip to content

Comparison of Non-mydriatic Camera Systems in a Female Health Hospital

Comparison of Non-mydriatic Camera Systems for Screening and Follow-up Examinations -Focused on the Retinal Vessel Situation- in the Population of a Female Health Hospital

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02089009
Enrollment
214
Registered
2014-03-17
Start date
2013-12-31
Completion date
2016-02-29
Last updated
2016-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases, Retina; Lesion, Optic Disc Structural Anomaly

Brief summary

1. To compare quality and usability of images taken by two different camera-systems without dilating the pupil. 2. To compare the retinal vessel diameters based on the images of to different camera-systems. 3. To detect changes in retinal vessel diameters while pregnancy and after delivery.

Detailed description

1. To compare quality and usability of images taken by two different camera-systems without dilating the pupil. Quality means in this content that images cover the planned region of interest and images should be sharp and good illuminated to see details for medical reading of retinal findings. 2. To compare the retinal vessel diameters based on the images of to different camera-systems. The diameters of arteries and veins are planned to be measured with an automated software algorithm. Are there differences in the calculated results between the two used camera devices? 3. To detect changes in retinal vessel diameters while pregnancy and after delivery. Are there detectable changes of the retinal findings between the images taken before and after delivery (e.g. bleeding, edema, vessel tortuosity)

Interventions

Retinal imaging by using non-mydriatic camera devices

Vessel measurements based on the taken images by the use of a specialized software

OTHERChange in vessel diameters

Change of vessel diameters before and after delivery based on the taken images by the use of a specialized software

Sponsors

Optomed
CollaboratorUNKNOWN
Dr. Martin Leitritz
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* written informed consent * age \>18 years * pregnancy (only group 2)

Exclusion criteria

* limited ability for agreement * heavy tremble * reduced general condition * known epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Image Quality12 to 16 monthVisit 1 and Visit 2 (for group 2) Evaluating of image quality for each camera-system

Secondary

MeasureTime frameDescription
Retinal Pathologies12 to 16 monthVisit 1 and Visit 2 (group 2) Which pathologies / diseases can be assessed with the taken images.
Differences Perinatal12 to 16 monthVisit 1 and Visit 2 (group 2)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026